Rebecca C Abbott

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Prognostic Factors

Top Venues

Clinical & translational immunology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)
Rebecca C Abbott, Hannah E Hughes-Parry, Misty R Jenkins
To go or not to go? Biological logic gating engineered T cells. Journal for immunotherapy of cancer 10 (4) (2022)
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma. Clinical & translational immunology 10 (5) (2021)